Tumor Ablation Market Size, Company Share and Capacity Forecasts 2016

Hexa Reports
Market Research Reports and Insightful Company Profiles

Tumor Ablation Market Size, Share, Trend Analysis, Market
Growth By Technology Application And Segment Forecasts
To 2022

Global tumor ablation market is expected to reach USD 1.5 billion by 2022, according to a new study by
Grand View Research Inc. Rising prevalence of different forms of cancer and increasing technological
advancements in the field of thermal ablation techniques are the most prominent drivers of the market.
Besides the use of thermal ablation, techniques such as laser ablation, irreversible electroporation, High
Intensity Focused Ultrasonography (HIFU) are also clinically growing, concurrently propelling the tumor
ablation industry.
Browse Detail Report With TOC @
http://www.hexareports.com/report/tumor-ablation-market-size-forecast-by-technology/details
Occurrence of lung, breast, and liver cancer is on the rise globally. According to the Center for Disease
Control (CDC) and other organizations, currently, about 210,828 cases of lung cancer, 2.9 million cases
of breast cancer, and over 2.7 million cases of prostate cancer are reported in the U.S. alone.
In terms of technological advancement, companies such as SonaCare Medical are coupling ablation
techniques with other technologies to improve accuracy, performance, and level of care. SonaLink, a

Hexa Reports
Market Research Reports and Insightful Company Profiles
remote patient monitoring platform, was put to use along with Sonatherm ablation system to enable
physicians to enhance patient care experience, thereby promoting market growth.
The industry is also anticipated to witness mergers and joint collaborations as a tool to curb rising
competition. For instance, Boston Scientific Corporation acquired C.R. Bard Electrophysiology, which led
to a 48.0% hike in profit for the former company.
Further key findings from the study suggest:
Microwave ablation technology is expected to be the fastest growing segment over the forecast...